SEARCH RESULTS

36 RESULTS

Dennis Selkoe on A New Era of Alzheimer’s Treatment

COMMENT First and foremost, the FDA’s approval of aducanumab is a signal event for our patients and their families. For the first time, they have an option that may offer modification of the disease in the brain and some slowing of cognitive decline over time in ...

Dennis Selkoe on Biogen/Eisai Halt Phase 3 Aducanumab Trials

COMMENT This morning’s news that an interim analysis by Biogen of their Phase 3 clinical trials of their anti-amyloid antibody called aducanumab showed a lack of clinical benefit is a huge disappointment for our patients and for the field of therapeutics for ...

Current Filters

  • TYPE: Comment x
  • Commentator: Selkoe, Dennis x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE